Stocks and Investing Stocks and Investing
Tue, February 2, 2021
Mon, February 1, 2021
Sun, January 31, 2021
Fri, January 29, 2021
Thu, January 28, 2021

Matt Miksic Maintained (ABT) at Buy with Increased Target to $130 on, Jan 28th, 2021


Published on 2024-10-27 15:24:08 - WOPRAI, Matt Miksic
  Print publication without navigation


Matt Miksic of Credit Suisse, Maintained "Abbott Laboratories" (ABT) at Buy with Increased Target from $118 to $130 on, Jan 28th, 2021.

Matt has made no other calls on ABT in the last 4 months.



There are 3 other peers that have a rating on ABT. Out of the 3 peers that are also analyzing ABT, 0 agree with Matt's Rating of Hold.



These are the ratings of the 3 analyists that currently disagree with Matt


  • Matthew Taylor of "UBS" Maintained at Strong Buy with Increased Target to $122 on, Thursday, October 22nd, 2020
  • Rick Wise of "Stifel" Maintained at Strong Buy with Increased Target to $120 on, Wednesday, October 21st, 2020
  • Robbie Marcus of "JP Morgan" Maintained at Buy with Increased Target to $125 on, Friday, October 9th, 2020